-
3
-
-
0034043034
-
-
L. Genestier, R. Paillot, L. Quemeneur, K. Izeradjene, and J.P. Revillard Immunopharmacology 47 2000 247 257
-
(2000)
Immunopharmacology
, vol.47
, pp. 247-257
-
-
Genestier, L.1
Paillot, R.2
Quemeneur, L.3
Izeradjene, K.4
Revillard, J.P.5
-
4
-
-
0032605142
-
Mechanisms of Methotrexate. Resistance in Acute Leukemia. Decreased Transport and Polyglutamylation
-
G.J. Kaspers Plenum New York*et al.
-
R. Gorlick, P. Cole, D. Banerjee, G. Longo, W. Wei Li, D. Hochhauser, and J.R. Bertino Mechanisms of Methotrexate. Resistance in Acute Leukemia. Decreased Transport and Polyglutamylation G.J. Kaspers Drug Resistance in Leukemia and Lymphoma III 1999 Plenum New York 543 550
-
(1999)
Drug Resistance in Leukemia and Lymphoma III
, pp. 543-550
-
-
Gorlick, R.1
Cole, P.2
Banerjee, D.3
Longo, G.4
Wei Li, W.5
Hochhauser, D.6
Bertino, J.R.7
-
6
-
-
0030054105
-
-
J.R. Bertino, E. Göker, R. Gorlick, W.W. Li, and D. Banerjee Stem Cells 14 1996 5 9
-
(1996)
Stem Cells
, vol.14
, pp. 5-9
-
-
Bertino, J.R.1
Göker, E.2
Gorlick, R.3
Li, W.W.4
Banerjee, D.5
-
9
-
-
0021354218
-
-
A. Rosowsky, R.A. Forsch, C.S. Yu, H. Lazarus, and G.P. Beardsley J. Med. Chem. 27 1984 605 609
-
(1984)
J. Med. Chem.
, vol.27
, pp. 605-609
-
-
Rosowsky, A.1
Forsch, R.A.2
Yu, C.S.3
Lazarus, H.4
Beardsley, G.P.5
-
10
-
-
0024267021
-
-
U. Kuefner, U. Lohrmann, Y. Montejano, K.S. Vitols, and F.M. Huennekens Adv. Enzyme Regul. 27 1988 3 13
-
(1988)
Adv. Enzyme Regul.
, vol.27
, pp. 3-13
-
-
Kuefner, U.1
Lohrmann, U.2
Montejano, Y.3
Vitols, K.S.4
Huennekens, F.M.5
-
12
-
-
0024439981
-
-
J. Kralovec, G. Spencer, A.H. Blair, M. Mammen, M. Singh, and T. Ghose J. Med. Chem. 32 1989 2426 2431
-
(1989)
J. Med. Chem.
, vol.32
, pp. 2426-2431
-
-
Kralovec, J.1
Spencer, G.2
Blair, A.H.3
Mammen, M.4
Singh, M.5
Ghose, T.6
-
14
-
-
0343049111
-
-
J. Boratynski, A. Opolski, J. Wietrzyk, A. Gorski, and C. Radzikowski Cancer Lett. 148 2000 189 195
-
(2000)
Cancer Lett.
, vol.148
, pp. 189-195
-
-
Boratynski, J.1
Opolski, A.2
Wietrzyk, J.3
Gorski, A.4
Radzikowski, C.5
-
15
-
-
0041461021
-
-
V. Subr, J. Strohalm, T. Hirano, Y. Ito, and K. Ulbrich J. Controlled Release 49 1997 123 132
-
(1997)
J. Controlled Release
, vol.49
, pp. 123-132
-
-
Subr, V.1
Strohalm, J.2
Hirano, T.3
Ito, Y.4
Ulbrich, K.5
-
16
-
-
0036077673
-
-
K. Riebeseel, E. Biedermann, R. Löser, N. Breiter, R. Hanselmann, R. Mülhaupt, C. Unger, and F. Kratz Bioconjugate Chem. 13 2002 773 785
-
(2002)
Bioconjugate Chem.
, vol.13
, pp. 773-785
-
-
Riebeseel, K.1
Biedermann, E.2
Löser, R.3
Breiter, N.4
Hanselmann, R.5
Mülhaupt, R.6
Unger, C.7
Kratz, F.8
-
18
-
-
0026491007
-
-
T. Janaky, A. Juhasz, Z. Rekasi, P. Serfösö, J. Pinski, L. Bokser, G. Srkalovic, S. Milovanovic, T.W. Redding, G. Halmos, A. Nagy, and A.V. Schally Proc. Natl. Acad. Sci. U.S.A. 89 1992 10203 10207
-
(1992)
Proc. Natl. Acad. Sci. U.S.A.
, vol.89
, pp. 10203-10207
-
-
Janaky, T.1
Juhasz, A.2
Rekasi, Z.3
Serfösö, P.4
Pinski, J.5
Bokser, L.6
Srkalovic, G.7
Milovanovic, S.8
Redding, T.W.9
Halmos, G.10
Nagy, A.11
Schally, A.V.12
-
19
-
-
0026705613
-
-
K. Szepeshazi, A.V. Schally, A. Juhasz, A. Nagy, and T. Janaky Anti-Cancer Drugs 3 1992 109 116
-
(1992)
Anti-Cancer Drugs
, vol.3
, pp. 109-116
-
-
Szepeshazi, K.1
Schally, A.V.2
Juhasz, A.3
Nagy, A.4
Janaky, T.5
-
20
-
-
0034126277
-
-
R. Pignatello, G. Spampinato, V. Sorrenti, C. Di Giacomo, L. Vicari, J.J. McGuire, C.A. Russell, G. Puglisi, and I. Toth Eur. J. Pharm. Sci. 10 2000 237 245
-
(2000)
Eur. J. Pharm. Sci.
, vol.10
, pp. 237-245
-
-
Pignatello, R.1
Spampinato, G.2
Sorrenti, V.3
Di Giacomo, C.4
Vicari, L.5
McGuire, J.J.6
Russell, C.A.7
Puglisi, G.8
Toth, I.9
-
22
-
-
0035098298
-
-
M. Mazel, P. Clair, C. Rousselle, P. Vidal, J.-M. Scherrmann, D. Mathieu, and J. Temsamani Anti-Cancer Drugs 12 2001 107 116
-
(2001)
Anti-Cancer Drugs
, vol.12
, pp. 107-116
-
-
Mazel, M.1
Clair, P.2
Rousselle, C.3
Vidal, P.4
Scherrmann, J.-M.5
Mathieu, D.6
Temsamani, J.7
-
24
-
-
0020441466
-
-
J.T. Bolin, D.J. Filman, D.A. Matthews, R.C. Hamlin, and J. Kraut J. Biol. Chem. 257 1982 13650 13662
-
(1982)
J. Biol. Chem.
, vol.257
, pp. 13650-13662
-
-
Bolin, J.T.1
Filman, D.J.2
Matthews, D.A.3
Hamlin, R.C.4
Kraut, J.5
-
25
-
-
0024583590
-
-
U. Kuefner, U. Lorhmann, Y. Montejano, K.S. Vitols, and F.M. Huennekens Biochemistry 28 1989 2288 2297
-
(1989)
Biochemistry
, vol.28
, pp. 2288-2297
-
-
Kuefner, U.1
Lorhmann, U.2
Montejano, Y.3
Vitols, K.S.4
Huennekens, F.M.5
-
27
-
-
11144316697
-
Study on Solid-Phase Synthesis of Compounds, Containing Hydroxyamino Acids or Saccharides, by Taking Advantage of the Characteristics of Glutamic Acid
-
H. Aoyagi
-
T. Wakamiya, D. Yoshida, Y. Mizuki, K. Hanatani, Y. Yamaguchi, and T. Shimamoto Study on Solid-Phase Synthesis of Compounds, Containing Hydroxyamino Acids or Saccharides, by Taking Advantage of the Characteristics of Glutamic Acid H. Aoyagi Peptide Science 2001 391 394
-
(2001)
Peptide Science
, pp. 391-394
-
-
Wakamiya, T.1
Yoshida, D.2
Mizuki, Y.3
Hanatani, K.4
Yamaguchi, Y.5
Shimamoto, T.6
-
28
-
-
0027949498
-
-
A. Chavanieu, M. Ceccato, J. Chenu, C. Mendre, and B. Calas Protein Peptide Lett. 1 1994 50 53
-
(1994)
Protein Peptide Lett.
, vol.1
, pp. 50-53
-
-
Chavanieu, A.1
Ceccato, M.2
Chenu, J.3
Mendre, C.4
Calas, B.5
-
30
-
-
0034126420
-
-
C. Rousselle, P. Clair, J.-M. Lefauconnier, M. Kaczorek, J.-M. Scherrmann, and J. Temsamani Mol. Pharmacol. 57 2000 679 686
-
(2000)
Mol. Pharmacol.
, vol.57
, pp. 679-686
-
-
Rousselle, C.1
Clair, P.2
Lefauconnier, J.-M.3
Kaczorek, M.4
Scherrmann, J.-M.5
Temsamani, J.6
|